Publications by authors named "Jennifer Aung"

Claim this Profile
A
A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.
Aflah Roohullah, Adam Cooper, Anna J Lomax, Jennifer Aung, Alan Barge

Invest New Drugs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.
Allan 'Ben' Smith, Meera Agar, Geoff Delaney, Joseph Descallar, Kelsey Dobell-Brown, Jennifer Aung

Asia Pac J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis